Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/25/2010WO2010033726A2 Drug delivery composition comprising a self-assembled gelator
03/25/2010WO2010033719A1 Treatment for leukemia and idiopathic aplastic anemia
03/25/2010WO2010033692A1 Curcumin-containing polymers and water soluble curcumin derivatives as prodrugs or prodrug carriers
03/25/2010WO2010033686A1 Methods for improved cryo-chemotherapy tissue ablation
03/25/2010WO2010033678A2 Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt
03/25/2010WO2010033656A1 Coating with antimicrobial agents
03/25/2010WO2010033647A2 Cysteine labeling system and method of use thereof
03/25/2010WO2010033637A1 Dissolution of arterial plaque
03/25/2010WO2010033626A1 Compounds, compositions and methods comprising imidazole and triazole derivatives
03/25/2010WO2010033614A1 Stable solid oral dosage co-formulations
03/25/2010WO2010033598A2 System and method for utilizing microbubbles and liposomes as viral sequestering agents
03/25/2010WO2010033593A2 Rosin derived epoxides and curing agents
03/25/2010WO2010033576A1 Compositions for treating or delaying the onset of hair loss
03/25/2010WO2010033560A2 Sur1 inhibitors for therapy
03/25/2010WO2010033540A1 Crystalline forms of fentanyl alkaloid
03/25/2010WO2010033509A2 14-hydroxy-docosahexaenoic acid compounds
03/25/2010WO2010033507A1 Method of enhancing tgf-beta signalling
03/25/2010WO2010033481A1 Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
03/25/2010WO2010033466A1 Macrocyclic inhibitors of hepatitis c protease
03/25/2010WO2010033451A2 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators
03/25/2010WO2010033444A1 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
03/25/2010WO2010033421A1 Bicyclic dihydroimidazolone cgrp receptor antagonists
03/25/2010WO2010033393A1 Substituted 3 -amin0- 1-0x0 or thioxo-i, 2,5,6,7, 8-hexahydr0-2, 7-naphthyridine-4-carb0nitriles as selective alpha 2b antagonists
03/25/2010WO2010033392A2 Methods and kits for treating cluster headache disorders
03/25/2010WO2010033340A1 Influenza a virus inhibition
03/25/2010WO2010033339A1 Inhibition of influenza m2 proton channel
03/25/2010WO2010033270A1 Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
03/25/2010WO2010033258A1 A novel lodinated resin manufacturing process and product
03/25/2010WO2010033248A2 Neutral nanotransporters
03/25/2010WO2010033247A2 Reduced size self-delivering rnai compounds
03/25/2010WO2010033246A1 Rna interference in skin indications
03/25/2010WO2010033236A2 Methods and compositions for treating bacterial infections by inhibiting quorum sensing
03/25/2010WO2010033219A2 Protease inhibitors having enhanced features
03/25/2010WO2010033198A2 Analogs of indole-3-carbinol and their use as agents against infection
03/25/2010WO2010033196A2 Simplified one-pot synthesis of [18f]sfb for radiolabeling
03/25/2010WO2010033188A2 Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
03/25/2010WO2010033168A2 Amide compounds, compositions and uses thereof
03/25/2010WO2010033074A1 Use of a tlr7 agonist for the treatment of cancer
03/25/2010WO2010033045A1 Compositions and methods for prevention or treatment of beta amyloid deposition
03/25/2010WO2010033043A1 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof
03/25/2010WO2010033014A2 Method for preparation of regenerative imidazolium reagents
03/25/2010WO2010033011A1 Rosamine derivatives as agents for the treatment of cancer
03/25/2010WO2010032976A2 Composition for prevention or treatment of heart failure
03/25/2010WO2010032974A2 Improved production method for adefovir dipivoxil
03/25/2010WO2010032880A2 Prophylactic/therapeutic agent for cancer
03/25/2010WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same
03/25/2010WO2010032771A1 Amino acid derivative
03/25/2010WO2010032731A1 Benzimidazole compound in crystal form and salt thereof
03/25/2010WO2010032704A1 Pharmaceutical preparation comprising micro-rna-143 derivative
03/25/2010WO2010032696A1 Diagnosis method and therapeutic method for cancer
03/25/2010WO2010032582A1 Therapeutic agent for adult t-cell leukemia
03/25/2010WO2010032489A1 Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions
03/25/2010WO2010032461A1 Nitrogen-containing fused ring compound
03/25/2010WO2010032448A1 Sheet for repairing cartilage defect site
03/25/2010WO2010032436A1 Antitumor agent containing 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic acid
03/25/2010WO2010032434A1 Composite organic compound powder for medical use, method for producing same and suspension of same
03/25/2010WO2010032269A2 Anti-inflammatory activity of the iridoid glycosides
03/25/2010WO2010032266A2 Novel single unit carbapenem aminoglycoside formulations
03/25/2010WO2010032257A1 Aryl indolyl sulfonamide compounds and their use as 5-ht6 ligands
03/25/2010WO2010032220A1 Stable liquid antibody formulation
03/25/2010WO2010032200A1 Amide compounds useful in therapy
03/25/2010WO2010032195A1 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
03/25/2010WO2010032177A1 Methods and compositions for diagnosing and treating a colorectal adenocarcinoma
03/25/2010WO2010032154A2 Method for the diagnosis of proventricular dilatation disease and kit thereof
03/25/2010WO2010032131A1 Platinum complex with antitumor activity
03/25/2010WO2010032128A1 Pharmaceutical dosage forms comprising poly(e-caprolactone)
03/25/2010WO2010032123A1 Triterpenoid compounds and methods of use thereof
03/25/2010WO2010032113A2 Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin
03/25/2010WO2010032073A1 Use of opioid antagonists for the preparation of a medicament in the treatment of retinal degenerative diseases
03/25/2010WO2010032043A2 Formulations
03/25/2010WO2010032041A2 Formulations
03/25/2010WO2010032010A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use
03/25/2010WO2010032009A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
03/25/2010WO2010031876A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments
03/25/2010WO2010031866A1 Lactose and cellulose-based tableting aid
03/25/2010WO2010031859A1 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
03/25/2010WO2010031852A1 Novel estrogen receptor ligands
03/25/2010WO2010031835A2 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
03/25/2010WO2010031832A2 Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative
03/25/2010WO2010031829A1 Synergistic combinations of a macrocyclic inhibitor of hcv and a nucleoside
03/25/2010WO2010031828A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer
03/25/2010WO2010031820A1 Glucoside derivatives and uses thereof as sglt inhibitors
03/25/2010WO2010031819A1 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers.
03/25/2010WO2010031816A1 3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
03/25/2010WO2010031813A1 Glycoside derivatives and uses thereof
03/25/2010WO2010031809A1 Use of azaperone for reducing antibiotic usage
03/25/2010WO2010031805A1 Use of azaperone for improving growth performance
03/25/2010WO2010031801A2 Composition and methods for modulating toll-like receptor activity
03/25/2010WO2010031791A1 New compounds ii
03/25/2010WO2010031789A1 New compounds i
03/25/2010WO2010031785A1 Pharmaceutical composition for the treatment of gastrointestinal irritation disorders
03/25/2010WO2010031766A1 Pharmaceutical combination of 1-(2-tetrahydrofuryl)-5-fluorouracil and caffeic acid phenethyl ester for oral treating of tumors
03/25/2010WO2010031750A1 Organic compounds for applications in bacterial infections treatment
03/25/2010WO2010031735A1 Piperazine d3 and 5-ht2a receptor modulators
03/25/2010WO2010031713A1 Substituted pyrrolidine-2-carboxamides
03/25/2010WO2010031589A1 Small molecule bradykinin b2 receptor modulators
03/25/2010WO2010031577A1 Use of bradykinin b1 receptor antagonists in intestinal fibrosis treatment
03/25/2010WO2010031552A1 Process for preparing snuff composition
03/25/2010WO2010031536A1 Nicotine-containing granulate
03/25/2010WO2010031519A1 Transcutaneous compositions for specific immuno-modulatory treatment
1 ... 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 ... 7860